General Knowledge MCQs
Topic Notes: General Knowledge
MCQs and preparation resources for competitive exams, covering important concepts, past papers, and detailed explanations.
Plato
- Biography: Ancient Greek philosopher (427–347 BCE), student of Socrates and teacher of Aristotle, founder of the Academy in Athens.
- Important Ideas:
- Theory of Forms
- Philosopher-King
- Ideal State
41
What is the primary function of the drug 'Lynkuet' (elinzanetant), which was approved by the FDA in October 2025?
Answer:
Treating vasomotor symptoms of menopause
Lynkuet (elinzanetant) was approved in October 2025 as a non-hormonal treatment for moderate-to-severe vasomotor symptoms, commonly known as hot flashes, associated with menopause.
42
In September 2025, West Virginia University scientists successfully used AI to detect which condition in rural patients using low-tech ECG data?
Answer:
Heart Failure
Scientists at West Virginia University developed AI models that could detect signs of heart failure using simple ECG data, significantly improving early diagnosis rates for underserved rural populations.
43
Which drug was approved by the FDA in November 2025 for treating relapsed or refractory acute myeloid leukemia (AML) with a susceptible nucleophosmin 1 mutation?
Answer:
Komzifti (ziftomenib)
Komzifti (ziftomenib) received FDA approval in November 2025 for treating adults with relapsed or refractory acute myeloid leukemia who have a specific nucleophosmin 1 (NPM1) mutation.
44
A November 2025 study revealed that venom from which creature could be used to develop molecules that kill breast cancer cells as effectively as chemotherapy?
Answer:
Amazonian scorpion
Research published in November 2025 showed that molecules derived from the venom of an Amazonian scorpion could kill breast cancer cells with efficacy comparable to chemotherapy, offering a new potential avenue for cancer treatment.
45
In late 2024, Google released which experimental AI model series designed specifically for the 'agentic era'?
Answer:
Gemini 2.0
Google released the first models in its Gemini 2.0 experimental series in December 2024, positioning them as models designed for the 'agentic era' with enhanced capabilities for taking actions and executing multi-step plans.
46
What specifically does the drug 'Redemplo' (plozasiran), approved by the FDA in November 2025, target in adults?
Answer:
High triglycerides
Redemplo (plozasiran) was approved by the FDA in November 2025 specifically to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS), a rare genetic disorder.
47
Researchers from UC Davis engineered which crop in November 2025 to encourage soil bacteria to convert atmospheric nitrogen into fertilizer, potentially reducing the need for synthetic fertilizers?
Answer:
Wheat
In November 2025, UC Davis researchers announced they had engineered wheat to secrete compounds that trigger soil bacteria to fix atmospheric nitrogen, creating a natural fertilizer system that could lower agricultural emissions.
48
Which major tech company unveiled significant updates to its humanoid robot 'Optimus' in October 2025, highlighting improvements in dexterity and balance?
Answer:
Tesla
Tesla unveiled updates to its Optimus humanoid robot in October 2025, demonstrating enhanced physical capabilities such as better balance, object manipulation, and autonomous navigation for factory and logistics applications.
49
In November 2025, the FDA approved which drug for the treatment of locally advanced or metastatic non-squamous non-small cell lung cancer with specific HER2 mutations?
Answer:
Hyrnuo (sevabertinib)
On November 19, 2025, the FDA approved Hyrnuo (sevabertinib) for treating adults with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) harboring activating HER2 tyrosine kinase domain mutations.
50
Which AI model, detailed in Nature Medicine in September 2025, was reported to outperform WHO recommendations in predicting flu vaccine strains?
Answer:
VaxSeer
VaxSeer, a new machine-learning platform detailed in Nature Medicine in September 2025, outperformed WHO recommendations by accurately matching dominant flu strains in retrospective tests, offering a potentially more accurate alternative for vaccine formulation.